Capstone Investment Advisors, LLC Celldex Therapeutics, Inc. Transaction History

Capstone Investment Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	BUY	$35.22 - $51.88 $225,830 - $332,654	6,412 Added 50.68%	19,065 $800,000
Q4 2023 Feb 12, 2024	BUY	$22.61 - $40.65 $286,084 - $514,344	12,653 New	12,653 $501,000
Q1 2021 May 17, 2021	SELL	$16.19 - $29.91 $434,361 - $802,455	-26,829 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$14.99 - $22.75 $402,166 - $610,359	26,829 New	26,829 $470,000

207

67.3M

1.69M

980K

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.22B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Capstone Investment Advisors, LLC with notifications on news.